DrugDashboards

Vibativ

telavancin hydrochloride · TELAVANCIN HYDROCHLORIDE 15 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Cumberland Pharmaceuticals Inc.

NDC 66220-0315-11 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicaid spend (2025)

$37,819
81 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $4,039.43 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA022110
TE code
Approval date
Sep 11, 2009
Patents / exclusivity
2 patents, 0 exclusivities
TypeNumber / codeExpires
patent7531623Jan 1, 2027
patent7531623Jan 1, 2027

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of telavancin hydrochloride (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Cumberland Pharmaceuticals Inc.TELAVANCIN HYDROCHLORIDE 15 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vibativ — NDC 66220-0315-11," retrieved September 3, 2026, https://drugdashboards.com/drug/66220031511.

Free to cite with attribution — see how the data is put together.